Navigation Links
US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
Date:7/11/2012

BELLEVUE, Wash., July 11, 2012 /PRNewswire/ -- Summit Associates International today announced that it was awarded US Patent 8,183,204, on methods and compositions for increasing skin remodeling. The patent describes the use of metal peptides for helping to diminish or remove various skin imperfections, including wound and surgical scars, acne scars, keloids, skin tags, benign skin moles, stretch marks, facial keratosis, sunspots, or a vitiligo.

The inventor, Dr. Loren Pickart, previously discovered the human skin-remodeling, copper-binding peptide GHK, and then developed clinically-proven methods for its use in cosmetic skin improvement, hair growth, and hair transplantation. Recent published work from numerous universities found that GHK controls or heavily influences 17% of the human genome, and also possesses a multiplicity of "wellness" properties including regeneration of tissues, activation of quiescent stem cells, suppression of numerous cancer metastasis genes, plus anti-inflammatory and anti-infection actions.

"The real cause of aging and most diseases is the silencing of regenerative and protective genes," said Dr. Pickart, "At age 25, our genes produce the healthiest mix of proteins, then gene silencing reduces the effect of our regenerative genes and increases the influence inflammatory and cancer-promoting genes. Summit Associates is also focused on developing and patenting methods of re-programming the human gene pattern to inhibit cancer growth and the effects of human senescence."

Summit Associates is Dr. Pickart's research group and located in Bellevue, WA. More information can be found at www.summit-associates-intl.com


Media contact:
Dr. Loren Pickart
425-644-0160
Email lorenpickart@summit-associate-intl.com


'/>"/>
SOURCE Summit Associates International
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Enbrel® (etanercept) Patent Issued
2. Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office
3. Cenestra Health Announces Granting of Broad Patent Covering Proprietary Bioactive Lipid Formulations
4. Silence Therapeutics Announces Positive Response by USPTO that Affirms Validity of Four Foundational RNAi Patents
5. Northwest Bio Reaffirms Its Freedom to Operate; Refutes Other Parties Misleading Patent Assertions
6. Bio-AMD, Inc.; DSR Commercial Refinement, Prospective Patent Applications
7. Ampio Pharmaceuticals Awarded Canadian Composition of Matter Patent That Strengthens IP Protection for Its Key Drug Ampion™
8. Arcion Receives Notice of Allowance for US Patent for Novel Topical Lidocaine Formulation for Pain
9. NanoLogix Instructs Third-Party to Prepare US FDA Submittals and is Granted US and Chinese Patents
10. Saladax Biomedical, Inc. Issued Six Patents Containing Broad Claims in the Immunoassay Space
11. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... October 22, 2014 According to ... by Service Type (Consulting, Integration, Deployment & Support), ... Deployment Model (Public, Private, Others (Hybrid & Community)) ... defines and segments the Cloud Professional Services Market ... forecasting of revenues. It also identifies the drivers ...
(Date:10/22/2014)... 22, 2014 Nuvilex, Inc. (OTCQB: NVLX) – ... people worldwide are living with diabetes, with  that number ... The global market for diabetes treatments is approximately $500 ... worldwide died from pancreatic cancer.  Pancreatic cancer is the ... in the United States , and ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market by product ... Table-top Counters) by End-user (Inpatient Pharmacy Automation, Outpatient ... 2019” analyzes and studies the major market drivers, ... and the Rest of the World (RoW). , ... through 300 pages and in-depth TOC on "Pharmacy ...
(Date:10/20/2014)... Calif. , Oct. 20, 2014 ... that the Company has signed a Notice of ... Regenerative Medicine (CIRM), effective October 1, 2014.  The ... Development payments and the release of additional grant ... CIRM grant award for clinical development of Asterias, ...
Breaking Biology Technology:Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 2Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 3Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 4Cloud Professional Services Market by Public, Private, Hybrid & Community Expected to Reach $34.41 Billion by 2019 - New Report by MarketsandMarkets 5Nuvilex Brief Analyst Report: Thinking Outside the Box by BrokerBank Securities, Inc. 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4
... CITY, Oct. 7 Great Basin Scientific, Inc., ... diagnostic solutions, today announced it had closed a ... in the,funding for this round., The new ... the spring of,2009 as it completes the design ...
... List for Fourth Consecutive Year, INDIANAPOLIS, ... one of the magazine,s Top 500 innovative ... a handful of companies in the biotech,and ... No. 86, in the 2008 report,outperformed others ...
... Vical Incorporated (Nasdaq:,VICL) and AnGes MG, Inc., ... mutual interest to license the development and marketing,rights ... to AnGes. AnGes,plans to conduct due diligence on ... to negotiate terms and conditions potentially leading,to a ...
Cached Biology Technology:Great Basin Scientific, Inc. Closes $3.9 Million in Equity Funding 2InformationWeek Puts Roche Diagnostics on Top 500 Innovative Tech Users List 2Vical and AnGes MG Sign Letter of Intent for Pandemic Influenza Program 2
(Date:10/22/2014)... Oct. 21, 2014 Aware, Inc. (NASDAQ: ... today reported financial results for its third quarter ended September ... 2014 was $6.0 million, an increase of 40% compared to ... in the third quarter of 2014 was $4.1 million compared ... operating income in the current three month period was primarily ...
(Date:10/18/2014)... and stress-related psychiatric disorders are associated with ... molecular mechanisms underlying this relation are unknown. ... development of targeted preventive strategies and new ... This work is presented at the European ... an international group of researchers from Germany ...
(Date:10/18/2014)... suspected genetic conditions, a certain type of exome sequencing ... than traditional molecular diagnostic methods, according to a study ... released to coincide with the American Society of Human ... protein­coding region of the genome (the complete set of ... organism), has been rapidly applied in research settings and ...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7Researchers find why depression and aging linked to increased disease risk 2Study examines type of exome sequencing and molecular diagnostic yield 2Study examines type of exome sequencing and molecular diagnostic yield 3
... to noise of a diverse range of crustaceans, an international ... families of crustaceans previously assumed to be deaf could detect, ... the Great Barrier Reef, the team collected nearly 700,000 crustaceans, ... each of 34 nights, one light trap was attached to ...
... MD FASEB MARC (Minority Access to Research Careers) ... American College of Sports Medicine (ACSM) Texas Chapter Annual ... awards are meant to promote the entry of underrepresented ... the basic science community and to encourage the participation ...
... ( www.ucr.edu ) -- Ever wonder how much fuel ... window, not using air conditioning or coasting toward stops? ... of Engineering Center for Environmental Research and Technology (CE-CERT) ... is called eco-driving, which refers to providing drivers with ...
Cached Biology News:Rowdy residents warn crustaceans away from perilous reefs 2Research helps drivers cut fuel use 2Research helps drivers cut fuel use 3
Human/Rat Neurogenin-2 MAb (Clone 7G4) Protein Family: Neural Crest Cell Markers, Transcription Factors...
Rat CINC-2 alpha/beta Affinity Purified Polyclonal Ab...
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Mouse TREM-2 Affinity Purified Polyclonal Ab...
Biology Products: